Monoclonal antibody-mediated tumor regression by induction of apoptosis.
about
The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosisThe prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activationMolecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell deathTAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteinsHistone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIPModulation of the CD95-induced apoptosis: the role of CD95 N-glycosylationA novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domainICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosisA cell surface receptor defined by a mAb mediates a unique type of cell death similar to oncosisIdentification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cellsPalmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signalingStructure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell deathTumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domainFLICE-inhibitory proteins: regulators of death receptor-mediated apoptosisCytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptorFas involvement in Ca(2+)-independent T cell-mediated cytotoxicityThe effects of chemotherapeutics on cellular metabolism and consequent immune recognitionExperimental models of hepatotoxicity related to acute liver failureRegulation of CD95/Fas signaling at the DISCDeath receptor-ligand systems in cancer, cell death, and inflammationGetting TRAIL back on track for cancer therapyThe naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathwayCD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cellsMorphological features of Murray Valley encephalitis virus infection in the central nervous system of swiss miceA series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potencyCellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complexApoptosis timelineInteraction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathwayAntibody-targeted radiation cancer therapyMolecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomainCD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growthThe role of c-FLIP in modulation of CD95-induced apoptosisPartial tolerance of subcutaneously transplanted xenogeneic tumour cell graft by Fas-mediated immunosuppressionBcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosisThe CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin AFas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene productFAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphomaTwo CD95 (APO-1/Fas) signaling pathwaysAn analysis of critical factors for quantitative immunoblotting.A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancer
P2860
Q22009525-9AEBC7D8-2082-4912-A84F-6F1E89BC1763Q22254032-3614A406-73E0-42AD-B4A2-784683C8E7CFQ24291507-8CD3553C-B25D-4A00-BE55-386CE8E24857Q24301604-D20D8F8F-CDD1-4389-A18D-D9DE40D6155CQ24302531-E39AFFB5-53C9-4E54-93D8-8D1D35961384Q24305009-1096283A-8AC8-432D-8294-1C66D4C2CA53Q24306835-8FFDDBAA-A173-45E9-AED7-F3E508275FA6Q24318803-F6B0CFCC-CB77-405F-8FAC-E0F453430549Q24319367-445C70CE-D144-413D-BBF2-6C4DE89E2AB6Q24319961-FF83FA75-38B7-43E9-A921-B75A12FEE58BQ24328893-FBAAB3AF-21FB-4889-9CAB-D6A0B291B632Q24533524-935EEE41-27F1-45C2-9D38-1E476F005AA7Q24537245-5C38B630-8E5C-4CE0-A50E-9C44954B3E96Q24548247-13A7D93F-919B-4418-91B7-7FAC89A5642CQ24597543-725B14EE-8305-4DB0-950D-481006668E8AQ24680778-446F571A-A060-4771-A3D5-91CB5D4935F1Q24800960-0D448495-1224-435F-9924-25DA7E369AC5Q26775293-5FF7535C-B5B4-43D8-93C2-47501B08BDB1Q26824629-CEC37117-AD01-4211-8116-7BB4359D34B8Q26865568-2D334010-1C08-400C-8EFB-1794EA19DEAEQ27027460-FDCEA1A2-1A9B-4052-9CE2-7160FB7C9688Q27321306-EABC7F6A-9E2E-45F7-945E-32E19E57D0AAQ27329081-455D8D5D-4EC6-4AF2-B1B2-FF065179EB45Q27486646-D2214A8F-F235-4218-8201-C70EBE9DED4AQ27676800-E8C17A79-E9D1-4C0C-BDD1-1A59870D30DEQ28209029-7D98B068-A793-4630-836B-F8AF1C897C4BQ28215321-056ABEDF-998F-4EB5-823C-FF842CCFC46FQ28246191-3163B1AE-5F99-41C1-A8C5-8CBBEEB7E02DQ28264580-18721C8D-2086-45B5-831D-A5367AE929C1Q28268989-930C276A-C5E8-491C-8588-C3F9B72668D4Q28274504-D0DFA2E4-980C-4D23-88D8-5EE16033C4B9Q28293167-6DC4DBB0-7A4B-49FD-9D66-7AB2DB11C74AQ28366018-8EC67492-3D7E-4B8C-9D19-A61FE2DE21E3Q28588677-7BBF5188-DF71-4D62-86E0-BF04957D5126Q28610837-3C146335-3A2A-45DD-9459-6A00E0A57178Q28639862-DB5B1938-A632-490F-B2CF-526594AAC545Q28767089-BFD46A90-94DB-47FF-8FD7-0A5B6D1FBB51Q29619631-9C7E2B15-E96E-4731-A6A1-A698E5AF9940Q30300224-91566720-B8DE-4DDF-8EF8-A6E926B9FD4CQ30421880-B60AB31D-6B05-4F92-8792-38436C62ED0B
P2860
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
@en
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
@nl
type
label
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
@en
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
@nl
prefLabel
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
@en
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
@nl
P2093
P356
P1433
P1476
Monoclonal antibody-mediated tumor regression by induction of apoptosis.
@en
P2093
Krammer PH
P304
P356
10.1126/SCIENCE.2787530
P407
P577
1989-07-01T00:00:00Z